Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Revenue (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Revenue for 8 consecutive years, with $1.4 billion as the latest value for Q4 2025.

  • On a quarterly basis, Revenue rose 6.41% to $1.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $5.5 billion, a 5.12% increase, with the full-year FY2025 number at $5.5 billion, up 5.12% from a year prior.
  • Revenue was $1.4 billion for Q4 2025 at Select Medical Holdings, up from $1.4 billion in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.6 billion in Q1 2022 to a low of -$179.2 million in Q4 2023.
  • A 5-year average of $1.2 billion and a median of $1.3 billion in 2025 define the central range for Revenue.
  • Peak YoY movement for Revenue: plummeted 109.16% in 2022, then soared 832.36% in 2024.
  • Select Medical Holdings' Revenue stood at $1.6 billion in 2021, then plummeted by 109.16% to -$142.9 million in 2022, then fell by 25.42% to -$179.2 million in 2023, then skyrocketed by 832.36% to $1.3 billion in 2024, then rose by 6.41% to $1.4 billion in 2025.
  • Per Business Quant, the three most recent readings for SEM's Revenue are $1.4 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.3 billion (Q2 2025).